Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX 09:52:02 2024-05-23 am EDT 5-day change 1st Jan Change
29.1 USD -1.69% Intraday chart for Pfizer, Inc. +0.59% +1.04%
Sales 2024 * 60.41B Sales 2025 * 62.7B Capitalization 168B
Net income 2024 * 7.51B Net income 2025 * 11.26B EV / Sales 2024 * 3.74 x
Net Debt 2024 * 58.11B Net Debt 2025 * 49.97B EV / Sales 2025 * 3.47 x
P/E ratio 2024 *
21 x
P/E ratio 2025 *
14.5 x
Employees 88,000
Yield 2024 *
5.7%
Yield 2025 *
5.82%
Free-Float 59.05%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.29%
1 week+2.71%
Current month+15.53%
1 month+12.72%
3 months+7.44%
6 months-2.37%
Current year+2.81%
More quotes
1 week
28.32
Extreme 28.32
29.63
1 month
25.20
Extreme 25.2
29.63
Current year
25.20
Extreme 25.2
30.28
1 year
25.20
Extreme 25.2
40.37
3 years
25.20
Extreme 25.2
61.71
5 years
25.20
Extreme 25.2
61.71
10 years
25.20
Extreme 25.2
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-05-23 29.09 -1.72% 2 630 382
24-05-22 29.6 +3.64% 46,987,481
24-05-21 28.56 +0.11% 28,119,948
24-05-20 28.53 -0.38% 22,423,283
24-05-17 28.64 -0.97% 26,106,406

Delayed Quote Nyse, May 22, 2024 at 04:00 pm EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.6 USD
Average target price
31.94 USD
Spread / Average Target
+7.90%
Consensus